GO:0002446 neutrophil mediated immunity: Immune Defense Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002446 neutrophil mediated immunity describes any process involved in carrying out an immune response by a neutrophil, the most abundant circulating leukocyte in humans.
• Neutrophils execute immunity through phagocytosis, degranulation, reactive oxygen species production, and neutrophil extracellular trap (NET) formation.
• Neutrophil mediated immunity is not limited to direct killing; neutrophils also regulate innate and adaptive immunity via myeloperoxidase and cytokine release.
• Dysregulated neutrophil immunity contributes to inflammatory bowel disease, malaria pathology, cancer progression, and impaired responses to Staphylococcus aureus.
• Microbiota-derived metabolites such as butyrate constrain neutrophil functions, linking host metabolism to neutrophil mediated immunity.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of genes controlling neutrophil mediated immunity.
Description
Neutrophil mediated immunity (GO:0002446) is the biological process by which neutrophils, the most abundant circulating leukocytes in humans, carry out immune responses. This term encompasses all processes involved in the execution of immunity by a neutrophil, including pathogen recognition, phagocytosis, degranulation, reactive oxygen species (ROS) production, and the release of neutrophil extracellular traps (NETs). Because neutrophils are rapidly recruited to sites of infection and inflammation, this process is a first line of host defense and a key determinant of inflammatory pathology. Understanding GO:0002446 is therefore central to immunology, infectious disease, and inflammation research. Beyond direct antimicrobial activity, neutrophil mediated immunity shapes the broader immune landscape. Neutrophils regulate innate and adaptive immunity through the release of myeloperoxidase (MPO) and other mediators that modulate dendritic cells, macrophages, and T cells. Neutrophil extracellular traps activate proinflammatory functions of human neutrophils, amplifying inflammatory circuits. Consequently, dysregulation of this process is implicated in conditions ranging from inflammatory bowel disease to malaria and cancer. For researchers, GO:0002446 provides a structured framework to annotate and interpret gene function in neutrophil biology. Genes involved in granulopoiesis, chemotaxis, phagocytosis, and NET formation can be mapped to this term, enabling functional enrichment analysis and hypothesis-driven experiments. This article reviews the definition, mechanisms, key genes, disease links, and research methods relevant to neutrophil mediated immunity.
neutrophil mediated immunity At A Glance
| GO ID | GO:0002446 |
|---|---|
| GO term | neutrophil mediated immunity |
| Ontology | biological_process |
| Synonym | none |
| Major function | Execution of immune responses by neutrophils, including phagocytosis, degranulation, ROS production, and NET formation |
| Related cell type | Neutrophil (polymorphonuclear leukocyte) |
| Related processes | Granulopoiesis, chemotaxis, phagocytosis, NETosis, cytokine secretion |
| Disease relevance | Inflammatory bowel disease, malaria, cancer, Staphylococcus aureus infection |
| Research methods | CRISPR knockout/knock-in, RNA-seq, proteomics, imaging, functional assays |
What Is GO:0002446?
According to the Gene Ontology, GO:0002446 (neutrophil mediated immunity) is defined as any process involved in the carrying out of an immune response by a neutrophil. It is a biological_process term that covers the effector and regulatory activities through which neutrophils contribute to immunity, including pathogen killing, inflammatory mediator release, and modulation of other immune cells.
Why Is neutrophil mediated immunity Important in Cell Biology?
Neutrophil mediated immunity is essential for host defense against bacterial and fungal pathogens, yet its dysregulation drives tissue damage in inflammatory and autoimmune diseases. Because neutrophils are the first responders to infection, understanding GO:0002446 informs vaccine design, anti-infective strategies, and anti-inflammatory therapies. Moreover, neutrophil heterogeneity and plasticity influence tumor progression and immunotherapy outcomes, making this process a high-priority research area.
• Provides first-line defense against bacterial and fungal pathogens through phagocytosis and killing.
• Regulates adaptive immunity via myeloperoxidase and cytokine-mediated crosstalk with T cells and dendritic cells.
• NET formation amplifies inflammation and can contribute to tissue injury in autoimmune and inflammatory diseases.
• Dysregulated neutrophil immunity is a hallmark of inflammatory bowel disease, where butyrate constrains neutrophil functions.
• Neutrophils play dual roles in malaria, contributing to both parasite control and immunopathology.
• Staphylococcus aureus evades neutrophil-mediated killing, highlighting the process as a target for anti-virulence strategies.
• Innate immune training of granulopoiesis can enhance anti-tumor activity, linking neutrophil immunity to cancer therapy.
• Aging of the immune system alters neutrophil function, affecting susceptibility to infection in older adults.
• Neutrophil diversity and function are increasingly recognized as context-dependent, requiring precise experimental models.
• CRISPR screening enables systematic discovery of genes regulating neutrophil mediated immunity.
What Happens During neutrophil mediated immunity?
Recognition and Chemotaxis
In simple terms: Neutrophils sense signals from infection or damage and move toward the source.
Neutrophil mediated immunity begins with the detection of pathogen-associated or damage-associated molecular patterns, followed by directed migration (chemotaxis) to inflamed tissues. Chemokine gradients and adhesion molecules guide neutrophils from circulation into tissue. This recruitment step is essential for effective immunity and is modulated by inflammatory mediators.
Phagocytosis and Intracellular Killing
In simple terms: Neutrophils engulf microbes and destroy them inside the cell.
Upon recognition, neutrophils internalize pathogens into phagosomes, which fuse with granules containing antimicrobial peptides and proteases. The phagocyte NADPH oxidase complex assembles to produce reactive oxygen species (ROS), a process critical for microbial killing. Myeloperoxidase (MPO) further converts hydrogen peroxide into hypochlorous acid, enhancing microbicidal activity.
Degranulation and Antimicrobial Peptide Release
In simple terms: Neutrophils release toxic granules to kill microbes outside the cell.
Neutrophils contain primary (azurophilic), secondary (specific), and tertiary granules that store antimicrobial proteins such as MPO, elastase, and defensins. Upon activation, these granules fuse with the phagosome or plasma membrane, releasing their contents to degrade pathogens and modulate inflammation. MPO release is a key effector mechanism of neutrophil mediated immunity.
Neutrophil Extracellular Trap (NET) Formation
In simple terms: Neutrophils can cast web-like structures of DNA to trap and kill microbes.
NETs are extracellular webs of DNA, histones, and antimicrobial proteins released by neutrophils in a process termed NETosis. NETs immobilize and kill pathogens, but also activate proinflammatory functions of human neutrophils, amplifying inflammation. Excessive NET formation is implicated in autoimmune and inflammatory tissue damage.
Regulation of Innate and Adaptive Immunity
In simple terms: Neutrophils also send signals that shape the overall immune response.
Beyond direct killing, neutrophils regulate innate and adaptive immunity through the release of cytokines and MPO, influencing dendritic cell maturation and T cell responses. Neutrophil-derived mediators can either promote or resolve inflammation depending on context. This regulatory role positions neutrophil mediated immunity as a central node in immune coordination.
Key Genes Involved in GO:0002446 neutrophil mediated immunity
The following genes and proteins are experimentally implicated in neutrophil mediated immunity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MPO | Myeloperoxidase; produces hypochlorous acid for microbial killing and regulates immunity | Key effector and immunomodulatory enzyme in neutrophil mediated immunity |
| ELANE | Neutrophil elastase; degrades pathogens and matrix proteins | Granule protease central to neutrophil function |
| CYBB | NADPH oxidase subunit; produces ROS for killing | Mutations cause chronic granulomatous disease |
| NCF1 | NADPH oxidase component; ROS production | Target for functional studies of oxidative killing |
| PADI4 | Peptidylarginine deiminase 4; citrullinates histones during NETosis | Regulates NET formation |
| CXCR2 | Chemokine receptor mediating neutrophil recruitment | Controls chemotaxis and tissue infiltration |
| ITGAM | Integrin subunit for adhesion and migration | Required for neutrophil extravasation |
| TLR4 | Pattern recognition receptor for LPS | Initiates neutrophil activation |
| FCGR3B | Fc gamma receptor for IgG; mediates phagocytosis | Links antibody responses to neutrophil killing |
| S100A8 | Calcium-binding protein; alarmin and antimicrobial | Marker of neutrophil activation |
| S100A9 | Calcium-binding protein; alarmin and antimicrobial | Marker of neutrophil activation |
| IL1B | Proinflammatory cytokine produced by neutrophils | Amplifies inflammatory responses |
| TNF | Proinflammatory cytokine released by neutrophils | Modulates inflammation and immunity |
| CSF3R | G-CSF receptor; regulates granulopoiesis | Target for innate immune training studies |
| GATA2 | Transcription factor for granulopoiesis | Regulates neutrophil development |
| CEBPE | Transcription factor for granulocyte differentiation | Controls neutrophil maturation |
| NLRP3 | Inflammasome component; IL-1beta processing | Links neutrophils to inflammasome biology |
| CASP1 | Caspase-1; inflammasome effector | Regulates inflammatory cytokine release |
How Is neutrophil mediated immunity Regulated?
Neutrophil mediated immunity is regulated at multiple levels, including transcriptional control of granulopoiesis by factors such as GATA2 and CEBPE, and post-transcriptional modulation by inflammatory signals. Microbiota-derived metabolites, such as butyrate, constrain neutrophil functions and ameliorate mucosal inflammation, indicating metabolic regulation of this process. Innate immune training of granulopoiesis can enhance anti-tumor activity, demonstrating epigenetic and functional reprogramming of neutrophils. Additionally, NET formation is regulated by PADI4-mediated histone citrullination and ROS-dependent pathways.
neutrophil mediated immunity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MPO | Inflammatory bowel disease; immunomodulation | MPO knockout mice or human neutrophil-like cell lines |
| PADI4 | NETosis-related autoimmune and inflammatory diseases | PADI4 knockout or point-mutation models |
| CYBB | Chronic granulomatous disease; defective ROS production | CYBB knockout iPSC-derived neutrophils |
| CSF3R | Neutropenia; innate immune training | CSF3R knock-in or knockout models |
| FCGR3B | Autoimmune neutropenia; phagocytosis defects | FCGR3B overexpression or knockout cell lines |
Inflammatory Bowel Disease
Neutrophil mediated immunity is a major contributor to mucosal inflammation in inflammatory bowel disease (IBD). Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation, suggesting that metabolic regulation of neutrophils can be therapeutically exploited. Excessive neutrophil activation and NET formation can damage intestinal epithelium, while impaired neutrophil function may predispose to infection.
Malaria
Neutrophils are key players in malaria pathogenesis, contributing to both parasite control and immunopathology. Neutrophil mediated immunity can exacerbate inflammation in severe malaria, and neutrophil dysfunction is associated with poor outcomes. Understanding neutrophil biology in malaria may inform adjunctive therapies.
Staphylococcus aureus Infection
Staphylococcus aureus has evolved multiple mechanisms to evade neutrophil mediated killing, including inhibition of phagocytosis and neutralization of antimicrobial peptides. This immune evasion contributes to recurrent and severe infections, making neutrophil-pathogen interactions a target for anti-virulence strategies.
Cancer
Neutrophils can exert both pro-tumor and anti-tumor effects depending on context. Innate immune training of granulopoiesis promotes anti-tumor activity, highlighting the potential to harness neutrophil mediated immunity in cancer immunotherapy. Neutrophil diversity and plasticity are critical determinants of tumor progression.
From neutrophil mediated immunity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate neutrophil ROS production? | CRISPR knockout in HL-60 or PLB-985 cells differentiated to neutrophils |
| Does a point mutation in MPO alter enzymatic activity? | CRISPR point-mutation knock-in in neutrophil-like cell lines |
| Does overexpression of PADI4 enhance NET formation? | CRISPR knock-in of a constitutive promoter or lentiviral overexpression |
| Does tagged MPO localize to granules? | CRISPR knock-in of fluorescent or epitope tag |
| Does gene Y affect neutrophil chemotaxis? | CRISPR knockout in primary human neutrophils or iPSC-derived neutrophils |
| Does innate immune training alter granulopoiesis? | In vivo mouse models with CSF3R or GATA2 modifications |
How to Study the neutrophil mediated immunity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene requirement for neutrophil function | Discovery of regulators of ROS production or NETosis |
| RNA-seq | Transcriptional changes during neutrophil activation | Pathway analysis and biomarker discovery |
| Proteomics | Protein abundance and modifications | Identification of effector proteins |
| Live-cell imaging | Phagocytosis, degranulation, NET formation | Functional validation of candidate genes |
| ROS detection assays | Reactive oxygen species production | Assessment of NADPH oxidase activity |
| Bacterial killing assays | Microbicidal capacity | Evaluation of neutrophil mediated immunity |
| Flow cytometry | Surface marker expression and viability | Neutrophil phenotyping |
| ELISA | Cytokine and MPO release | Quantification of inflammatory mediators |
CRISPR Functional Genomics
CRISPR knockout and knock-in screens enable systematic discovery of genes regulating neutrophil mediated immunity. Pooled screens in neutrophil-like cell lines can identify regulators of ROS production, phagocytosis, and NET formation. These approaches provide causal links between genes and neutrophil functions.
Transcriptomics and Proteomics
RNA-seq and proteomics characterize gene expression and protein abundance during neutrophil activation. These methods reveal signaling pathways and effector molecules involved in neutrophil mediated immunity. Integration with GO:0002446 enrichment analysis helps interpret functional relevance.
Imaging and Functional Assays
Live-cell imaging, immunofluorescence, and electron microscopy visualize phagocytosis, degranulation, and NET formation. Functional assays such as bacterial killing assays and ROS detection quantify neutrophil effector functions. These methods are essential for validating gene function in neutrophil mediated immunity.
In Vivo Models
Mouse models of infection and inflammation allow assessment of neutrophil mediated immunity in a physiological context. Adoptive transfer and lineage tracing can dissect neutrophil contributions to disease. These models are critical for translational research.
How CRISPR Can Be Used to Study GO:0002446 neutrophil mediated immunity
Knockout
CRISPR knockout of candidate genes in neutrophil-like cell lines or primary neutrophils enables loss-of-function studies to determine necessity for neutrophil mediated immunity. For example, knockout of CYBB abolishes ROS production, while MPO knockout impairs microbial killing. These models are foundational for causal inference.
Point Mutation
CRISPR point-mutation knock-in allows precise modeling of disease-associated variants in genes such as MPO or PADI4. This approach distinguishes catalytic activity from scaffolding functions and can reveal dominant-negative or gain-of-function effects.
Knock-in
Knock-in of fluorescent or epitope tags enables real-time tracking of proteins like MPO or ELANE during neutrophil activation. Knock-in of reporter genes under endogenous promoters provides physiological expression readouts for high-content screening.
Overexpression
CRISPR-mediated overexpression or lentiviral delivery of genes such as PADI4 or CSF3R can test sufficiency for enhanced neutrophil functions, including NET formation and granulopoiesis. Overexpression models complement knockout studies to establish causality.
How EDITGENE Supports neutrophil mediated immunity Research
Researchers studying neutrophil mediated immunity-related genes often need to determine whether a candidate gene is causally involved in neutrophil effector functions or merely correlated with activation. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for neutrophil mediated immunity research.
Frequently Asked Questions About neutrophil mediated immunity
What is GO:0002446 neutrophil mediated immunity?
GO:0002446 is a Gene Ontology biological process term defined as any process involved in the carrying out of an immune response by a neutrophil.
What genes are involved in neutrophil mediated immunity?
Key genes include MPO, ELANE, CYBB, NCF1, PADI4, CXCR2, ITGAM, TLR4, and FCGR3B, among others.
How do neutrophils kill pathogens?
Neutrophils kill pathogens through phagocytosis, ROS production, degranulation of antimicrobial peptides, and NET formation.
What are neutrophil extracellular traps?
NETs are web-like structures of DNA, histones, and antimicrobial proteins released by neutrophils to trap and kill microbes, and they also amplify inflammation.
How is neutrophil mediated immunity regulated?
It is regulated by transcription factors such as GATA2 and CEBPE, by metabolites like butyrate, and by signaling pathways controlling NETosis.
What diseases involve dysregulated neutrophil mediated immunity?
Inflammatory bowel disease, malaria, Staphylococcus aureus infection, and cancer are associated with altered neutrophil mediated immunity.
How can I study neutrophil mediated immunity in the lab?
Common methods include CRISPR knockout/knock-in, RNA-seq, proteomics, imaging, ROS assays, and bacterial killing assays.
What is the role of myeloperoxidase in neutrophil mediated immunity?
MPO produces hypochlorous acid for microbial killing and regulates innate and adaptive immunity.
Can CRISPR be used to study neutrophil mediated immunity?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal dissection of genes regulating neutrophil functions.
What cell models are used for neutrophil research?
HL-60 and PLB-985 cell lines differentiated into neutrophil-like cells, as well as iPSC-derived neutrophils and primary human neutrophils, are commonly used.
Conclusion
Neutrophil mediated immunity (GO:0002446) is a fundamental biological process that encompasses the diverse effector and regulatory functions of neutrophils in host defense and inflammation. Its dysregulation contributes to infectious, inflammatory, and malignant diseases, making it a critical area of research. Advances in CRISPR technology and functional genomics now allow precise interrogation of the genes controlling this process, offering new opportunities for therapeutic intervention.
References
- 1. Kalafati L et al.. 2020. Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity.. Cell 183(3):771-785.e12 PMID: 33125892
- 2. de Jong NWM et al.. 2019. Immune Evasion by Staphylococcus aureus.. Microbiol Spectr 7(2) PMID: 30927347
- 3. Zhang F et al.. 2024. Neutrophil diversity and function in health and disease.. Signal Transduct Target Ther 9(1):343 PMID: 39638788
- 4. Weiskopf D et al.. 2009. The aging of the immune system.. Transpl Int 22(11):1041-50 PMID: 19624493
- 5. Li G et al.. 2021. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease.. Gut Microbes 13(1):1968257 PMID: 34494943
- 6. Odobasic D et al.. 2016. Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase.. J Immunol Res 2016:2349817 PMID: 26904693
- 7. Dömer D et al.. 2021. Neutrophil Extracellular Traps Activate Proinflammatory Functions of Human Neutrophils.. Front Immunol 12:636954 PMID: 34168641
- 8. Aitken EH et al.. 2018. Neutrophils and Malaria.. Front Immunol 9:3005 PMID: 30619354
